irbesartan and hydrochlorothiazide
Generic: irbesartan and hydrochlorothiazide
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
irbesartan and hydrochlorothiazide
Generic Name
irbesartan and hydrochlorothiazide
Labeler
aurobindo pharma limited
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
hydrochlorothiazide 25 mg/1, irbesartan 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65862-631
Product ID
65862-631_6f7c3d7b-9b7c-447e-8763-f68a55ce4b91
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203630
Listing Expiration
2026-12-31
Marketing Start
2016-03-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862631
Hyphenated Format
65862-631
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
irbesartan and hydrochlorothiazide (source: ndc)
Generic Name
irbesartan and hydrochlorothiazide (source: ndc)
Application Number
ANDA203630 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
- 300 mg/1
Packaging
- 500 TABLET, FILM COATED in 1 BOTTLE (65862-631-05)
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-631-30)
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-631-90)
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-631-99)
Packages (4)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6f7c3d7b-9b7c-447e-8763-f68a55ce4b91", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0365862630308", "0365862629302", "0365862631305"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792", "310793", "485471"], "spl_set_id": ["466dd0d2-9815-4c3e-b66b-d0732b3ba8e9"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-631-05)", "package_ndc": "65862-631-05", "marketing_start_date": "20160331"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-631-30)", "package_ndc": "65862-631-30", "marketing_start_date": "20160331"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (65862-631-90)", "package_ndc": "65862-631-90", "marketing_start_date": "20160331"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (65862-631-99)", "package_ndc": "65862-631-99", "marketing_start_date": "20160331"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "65862-631_6f7c3d7b-9b7c-447e-8763-f68a55ce4b91", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "65862-631", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "IRBESARTAN", "strength": "300 mg/1"}], "application_number": "ANDA203630", "marketing_category": "ANDA", "marketing_start_date": "20160331", "listing_expiration_date": "20261231"}